In this regard, an initial experiment to sensitise DLBCL cell lines to an MCL-1 inhibitor (S63845) using SBI-756 (Fig. S9b) yielded a similar response as the venetoclax combination. Here, MCL1 is linked to diffuse large B-cell lymphoma.